Inflammatory Bowel Diseases 1990
Autor Daniel Rachmilewitz, J. Zimmerman, International Symposium on Inflammatoryen Limba Engleză Hardback – 28 feb 1990
Preț: 1421.74 lei
Preț vechi: 1496.57 lei
-5%
Puncte Express: 2133
Carte tipărită la comandă
Livrare economică 19 septembrie-03 octombrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9780792306573
ISBN-10: 0792306570
Pagini: 296
Ilustrații: XII, 280 p.
Dimensiuni: 160 x 241 x 21 mm
Greutate: 0.61 kg
Ediția:1990 edition
Editura: Springer Nature B.V.
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0792306570
Pagini: 296
Ilustrații: XII, 280 p.
Dimensiuni: 160 x 241 x 21 mm
Greutate: 0.61 kg
Ediția:1990 edition
Editura: Springer Nature B.V.
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
IBD: the present situation and a glimpse of the promised land.- IBD: the present situation and a glimpse of the promised land.- I: Etiology.- Is IBD a genetic disease?.- Glycoprotein structure and ulcerative colitis.- Barrier function of intestinal epithelial tight junctions (TJ).- Are mycobacteria the cause of Crohn’s disease?.- Smoking and inflammatory bowel disease.- II: Pathogenesis and experimental models.- Role of platelet activating factor and interleukin I in the pathogenesis of inflammatory bowel disease.- Is there a primary defect in the host defense mechanism in IBD?.- Evidence against a defect in immune host defenses as a primary process in IBD.- Animal models of inflammatory bowel disease.- III: Clinical assessment.- Why the variation in colitic cancer rates from different centres.- Is there any benefit from cancer surveillance in ulcerative colitis?.- Endoscopy in IBD — what has it accomplished?.- The problem of postoperative recurrence of Crohn’s disease.- Endoscopic examination of the small bowel in idiopathic inflammatory bowel diseases.- IV: Nutrition and metabolic implications.- Crohn’s disease in children and adolescents: diminished growth velocity.- Skeletal complications of inflammatory bowel disease.- Enteral nutrition in inflammatory bowel disease.- Total parenteral nutrition in the management of inflammatory bowel disease: an update.- V: Medical management.- 5-ASA in ulcerative colitis.- 5-ASA preparations in the treatment of inflammatory bowel disease.- 4-amino salicylic acid in the treatment of ulcerative colitis: preliminary report of a randomized double-blind placebo controlled trial of oral 4-ASA.- Olsalazine (Dipentum®): the first choice in the treatment of ulcerative colitis.- Immunosuppressive drugs: do they have any role in thetreatment of IBD? (A).- Immunosuppressive drugs: do they have any role in the treatment of IBD? (B).- Cyclosporin in inflammatory bowel disease.- Use of methotrexate for refractory inflammatory bowel disease.- Therapeutic strategies in IBD: Case discussion with computer-aided audience participation.- Index of subjects.